Epitomee Medical Ltd (EPIT) — Strategic Asset Allocation Index

Latest as of June 2023: 27.9%

Epitomee Medical Ltd (EPIT) has a Strategic Asset Allocation Index of 27.9% as of June 2023. Strategic assets (PP&E of ILA9.74 Million plus long-term investments of ILA-) total ILA9.74 Million, measured against net assets of ILA34.98 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

27.9%

Strategic Assets / Net Assets

Strategic Assets

ILA9.74 Million

PP&E + LT Investments

PP&E

ILA9.74 Million

ILA

Net Assets

ILA34.98 Million

ILA

Annual Strategic Asset Allocation Index for Epitomee Medical Ltd (None–None)

The table below presents the year-by-year Strategic Asset Allocation Index for Epitomee Medical Ltd from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see EPIT stock market capitalisation.

Year	SAAI	Strategic Assets (ILA)	PP&E	LT Investments	Net Assets	Change (pp)

pp = percentage points